| Comparative study of circulating MMP‐7, CCL18, KL‐6, SP‐A, and SP‐D as disease markers of idiopathic pulmonary fibrosis K Hamai, H Iwamoto, N Ishikawa, Y Horimasu, T Masuda, S Miyamoto, ... Disease markers 2016 (1), 4759040, 2016 | 146 | 2016 |
| Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer Y Nakanishi, T Masuda, K Yamaguchi, S Sakamoto, Y Horimasu, ... Respiratory Investigation 57 (5), 451-459, 2019 | 95 | 2019 |
| FIZZ2/RELM-β induction and role in pulmonary fibrosis T Liu, HA Baek, H Yu, HJ Lee, BH Park, M Ullenbruch, J Liu, T Nakashima, ... The Journal of Immunology 187 (1), 450-461, 2011 | 78 | 2011 |
| Inhibition of plasminogen activator inhibitor-1 attenuates transforming growth factor-β-dependent epithelial mesenchymal transition and differentiation of fibroblasts to … K Omori, N Hattori, T Senoo, Y Takayama, T Masuda, T Nakashima, ... PloS one 11 (2), e0148969, 2016 | 77 | 2016 |
| Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis T Nakashima, A Yokoyama, Y Onari, H Shoda, Y Haruta, N Hattori, ... Journal of allergy and clinical immunology 121 (5), 1269-1276, 2008 | 55 | 2008 |
| Bone marrow CD11c+ cell–derived amphiregulin promotes pulmonary fibrosis L Ding, T Liu, Z Wu, B Hu, T Nakashima, M Ullenbruch, ... The Journal of Immunology 197 (1), 303-312, 2016 | 53 | 2016 |
| A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline M Fioravanti, T Nakashima, J Xu, A Garg BMJ open 4 (7), e005090, 2014 | 52 | 2014 |
| Association of preexisting interstitial lung abnormalities with immune checkpoint inhibitor–induced interstitial lung disease among patients with nonlung cancers K Shimoji, T Masuda, K Yamaguchi, S Sakamoto, Y Horimasu, ... JAMA Network Open 3 (11), e2022906-e2022906, 2020 | 44 | 2020 |
| Essential role of stem cell factor–c‐Kit signalling pathway in bleomycin‐induced pulmonary fibrosis L Ding, V Dolgachev, Z Wu, T Liu, T Nakashima, Z Wu, M Ullenbruch, ... The Journal of pathology 230 (2), 205-214, 2013 | 44 | 2013 |
| Lung bone marrow–derived hematopoietic progenitor cells enhance pulmonary fibrosis T Nakashima, T Liu, H Yu, L Ding, M Ullenbruch, B Hu, Z Wu, H Oguro, ... American journal of respiratory and critical care medicine 188 (8), 976-984, 2013 | 39 | 2013 |
| Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma K Tokumo, T Masuda, T Miyama, S Miura, K Yamaguchi, S Sakamoto, ... Lung Cancer 119, 21-24, 2018 | 38 | 2018 |
| IL‐12p40 is essential for the down‐regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure Y Onari, A Yokoyama, Y Haruta, T Nakashima, H Iwamoto, N Hattori, ... Clinical & Experimental Allergy 39 (2), 290-298, 2009 | 38 | 2009 |
| Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis B Hu, Z Wu, T Nakashima, SH Phan The American journal of pathology 180 (6), 2257-2267, 2012 | 37 | 2012 |
| Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis H Shoda, A Yokoyama, R Nishino, T Nakashima, N Ishikawa, Y Haruta, ... Biochemical and biophysical research communications 353 (4), 1004-1010, 2007 | 37 | 2007 |
| Serum high‐mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis K Yamaguchi, H Iwamoto, S Sakamoto, Y Horimasu, T Masuda, ... Respirology 25 (3), 275-280, 2020 | 35 | 2020 |
| Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts T Masuda, T Nakashima, M Namba, K Yamaguchi, S Sakamoto, ... Journal of Cellular and Molecular Medicine 23 (4), 2984-2994, 2019 | 31 | 2019 |
| Nicergoline improves dysphagia by upregulating substance P in the elderly T Nakashima, N Hattori, M Okimoto, J Yanagida, N Kohno Medicine 90 (4), 279-283, 2011 | 30 | 2011 |
| Circulating KL‐6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome T Nakashima, A Yokoyama, H Ohnishi, H Hamada, N Ishikawa, Y Haruta, ... Journal of internal medicine 263 (4), 432-439, 2008 | 29 | 2008 |
| Intratracheal administration of siRNA dry powder targeting vascular endothelial growth factor inhibits lung tumor growth in mice K Miwata, H Okamoto, T Nakashima, D Ihara, Y Horimasu, T Masuda, ... Molecular Therapy-Nucleic Acids 12, 698-706, 2018 | 28 | 2018 |
| Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis D Kawahara, N Imano, R Nishioka, K Ogawa, T Kimura, T Nakashima, ... Scientific Reports 11 (1), 16232, 2021 | 27 | 2021 |
Manabu AbeProfessor of Chemistry, Hiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
Manabu AbeProfessor of Chemistry, Hiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
Hideyuki OguroUniversity of Connecticut School of Medicine在 uchc.edu 的电子邮件经过验证